Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rothman

Showing results (601-610 of 662) with videos related to

Pageof 67
Sort By:
American Heart Journal|March 1, 2014
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillationMenno V Huisman, Gregory Y H Lip, Hans C Diener, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 16, 2022
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registryMenno V Huisman, Christine Teutsch, Shihai Lu, et al.
The Journal of Experimental Medicine|July 9, 2020
Lipocalin-2 counteracts metabolic dysregulation in obesity and diabetesIoanna Mosialou, Steven Shikhel, Na Luo, et al.
The Journal of Experimental Medicine|December 8, 2016
CD4+ T cell effector commitment coupled to self-renewal by asymmetric cell divisionsSimone A Nish, Kyra D Zens, Radomir Kratchmarov, et al.
Thrombosis and Haemostasis|December 7, 2017
Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II RegistryMichał Mazurek, Menno V Huisman, Kenneth J Rothman, et al.
Environment International|October 20, 2023
Air pollution and fecundability in a North American preconception cohort studyAmelia K Wesselink, Perry Hystad, Kipruto Kirwa, et al.
American Heart Journal|April 15, 2018
Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registryMenno V Huisman, Kenneth J Rothman, Miney Paquette, et al.
American Journal of Epidemiology|July 19, 2013
Safety of MF59-adjuvanted influenza vaccination in the elderly: results of a comparative study of MF59-adjuvanted vaccine versus nonadjuvanted influenza vaccine in northern ItalyMarco Villa, Steven Black, Nicola Groth, et al.
Pharmacoepidemiology and Drug Safety|December 22, 2016
The feasibility of using multiple databases to study rare outcomes: the potential effect of long-acting beta agonists with inhaled corticosteroid therapy on asthma mortalityCatherine B Johannes, Lisa J McQuay, Kirk D Midkiff, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 3, 2025
A Preconception Cohort Study of Nicotine Vaping and Incidence of Spontaneous AbortionAusten D Le, Chiyuan Amy Zhang, Abby L Chen, et al.
Pageof 67

Showing results (601-610 of 662) with videos related to

Sort By:
Pageof 67
American Heart Journal|March 1, 2014
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillationMenno V Huisman, Gregory Y H Lip, Hans C Diener, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 16, 2022
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registryMenno V Huisman, Christine Teutsch, Shihai Lu, et al.
The Journal of Experimental Medicine|July 9, 2020
Lipocalin-2 counteracts metabolic dysregulation in obesity and diabetesIoanna Mosialou, Steven Shikhel, Na Luo, et al.
The Journal of Experimental Medicine|December 8, 2016
CD4+ T cell effector commitment coupled to self-renewal by asymmetric cell divisionsSimone A Nish, Kyra D Zens, Radomir Kratchmarov, et al.
Thrombosis and Haemostasis|December 7, 2017
Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II RegistryMichał Mazurek, Menno V Huisman, Kenneth J Rothman, et al.
Environment International|October 20, 2023
Air pollution and fecundability in a North American preconception cohort studyAmelia K Wesselink, Perry Hystad, Kipruto Kirwa, et al.
American Heart Journal|April 15, 2018
Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registryMenno V Huisman, Kenneth J Rothman, Miney Paquette, et al.
American Journal of Epidemiology|July 19, 2013
Safety of MF59-adjuvanted influenza vaccination in the elderly: results of a comparative study of MF59-adjuvanted vaccine versus nonadjuvanted influenza vaccine in northern ItalyMarco Villa, Steven Black, Nicola Groth, et al.
Pharmacoepidemiology and Drug Safety|December 22, 2016
The feasibility of using multiple databases to study rare outcomes: the potential effect of long-acting beta agonists with inhaled corticosteroid therapy on asthma mortalityCatherine B Johannes, Lisa J McQuay, Kirk D Midkiff, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 3, 2025
A Preconception Cohort Study of Nicotine Vaping and Incidence of Spontaneous AbortionAusten D Le, Chiyuan Amy Zhang, Abby L Chen, et al.
Pageof 67